0001437749-22-016182.txt : 20220629 0001437749-22-016182.hdr.sgml : 20220629 20220629164006 ACCESSION NUMBER: 0001437749-22-016182 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220629 DATE AS OF CHANGE: 20220629 EFFECTIVENESS DATE: 20220629 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Panbela Therapeutics, Inc. CENTRAL INDEX KEY: 0001029125 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870543922 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-450719 FILM NUMBER: 221055134 BUSINESS ADDRESS: STREET 1: 712 VISTA BLVD #305 CITY: WACONIA STATE: MN ZIP: 55387 BUSINESS PHONE: 9524791196 MAIL ADDRESS: STREET 1: 712 VISTA BLVD #305 CITY: WACONIA STATE: MN ZIP: 55387 FORMER COMPANY: FORMER CONFORMED NAME: Sun BioPharma, Inc. DATE OF NAME CHANGE: 20150911 FORMER COMPANY: FORMER CONFORMED NAME: Cimarron Medical, Inc. DATE OF NAME CHANGE: 20150602 FORMER COMPANY: FORMER CONFORMED NAME: CIMARRON SOFTWARE INC DATE OF NAME CHANGE: 19961217 D 1 primary_doc.xml X0708 D LIVE 0001029125 Panbela Therapeutics, Inc. 712 Vista Blvd #305 Waconia MN MINNESOTA 55387 952-479-1196 DELAWARE Canary Merger Holdings, Inc. Sun BioPharma, Inc. Cimarron Medical, Inc. CIMARRON SOFTWARE INC Corporation true Jennifer K. Simpson 712 Vista Blvd. #305 Waconia MN MINNESOTA 55387 Executive Officer Director All securities issued as partial consideration for acquisition of Cancer Prevention Pharmaceuticals, Inc. Susan Horvath 712 Vista Blvd. #305 Waconia MN MINNESOTA 55387 Executive Officer Michael T. Cullen 712 Vista Blvd. #305 Waconia MN MINNESOTA 55387 Director Daniel Donovan 712 Vista Blvd. #305 Waconia MN MINNESOTA 55387 Director Arthur J. Fratamico 712 Vista Blvd. #305 Waconia MN MINNESOTA 55387 Director Jeffrey E. Jacob 712 Vista Blvd #305 Waconia MN MINNESOTA 55387 Director Jeffrey S. Mathiesen 712 Vista Blvd #305 Waconia MN MINNESOTA 55387 Director Robert D. Schemel 712 Vista Blvd #305 Waconia MN MINNESOTA 55387 Director Pharmaceuticals Decline to Disclose 06b false 2022-06-15 false true true true All securities issued as partial consideration for acquisition of Cancer Prevention Pharmaceuticals, Inc. 0 Indefinite 8800000 Indefinite false 70 0 0 0 false Panbela Therapeutics, Inc. /s/ Jennifer K. Simpson Jennifer K. Simpson President & CEO 2022-06-28